Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma

Stock Information for Delcath Systems Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Delcath Systems Inc.

Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems Reports First Quarter 2025 Results and Business Highlights
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO(TM) in Liver-Dominant Metastatic Breast Cancer
Delcath Systems to Host First Quarter 2025 Earnings Call
Beta Bionics Announces Board Appointment of Gerard Michel
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems Reports Fourth Quarter and Full Year 2024 Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.